Andrew Spaventa - Net Worth and Insider Trading
Andrew Spaventa Net Worth
The estimated net worth of Andrew Spaventa is at least $2 Million dollars as of 2024-05-25. Andrew Spaventa is the CEO of Singular Genomics Systems Inc and owns about 4,070,972 shares of Singular Genomics Systems Inc (OMIC) stock worth over $2 Million. Details can be seen in Andrew Spaventa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Spaventa has not made any transactions after 2023-11-17 and currently still holds the listed stock(s).
Transaction Summary of Andrew Spaventa
Andrew Spaventa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Spaventa owns 1 companies in total, including Singular Genomics Systems Inc (OMIC) .
Click here to see the complete history of Andrew Spaventa’s form 4 insider trades.
Insider Ownership Summary of Andrew Spaventa
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OMIC | Singular Genomics Systems Inc | 2023-11-17 | director & 10 percent owner & Chief Executive Officer |
Andrew Spaventa Latest Holdings Summary
Andrew Spaventa currently owns a total of 1 stock. Andrew Spaventa owns 4,070,972 shares of Singular Genomics Systems Inc (OMIC) as of November 17, 2023, with a value of $2 Million.
Latest Holdings of Andrew Spaventa
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMIC | Singular Genomics Systems Inc | 2023-11-17 | 4,070,972 | 0.38 | 1,551,040 |
Holding Weightings of Andrew Spaventa
Andrew Spaventa Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Spaventa has made a total of 1 transactions in Singular Genomics Systems Inc (OMIC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Singular Genomics Systems Inc is the acquisition of 118,468 shares on November 17, 2023, which cost Andrew Spaventa around $49,757.
Insider Trading History of Andrew Spaventa
- 1
Andrew Spaventa Trading Performance
GuruFocus tracks the stock performance after each of Andrew Spaventa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Spaventa is 25.21%. GuruFocus also compares Andrew Spaventa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Spaventa within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Spaventa's insider trading performs compared to the benchmark.
Performance of Andrew Spaventa
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.86 |  | | | | |
| Relative Return to S&P 500(%) | -7.41 | | | | | |
Andrew Spaventa Ownership Network
Andrew Spaventa Owned Company Details
What does Singular Genomics Systems Inc do?
Who are the key executives at Singular Genomics Systems Inc?
Andrew Spaventa is the director & 10 percent owner & Chief Executive Officer of Singular Genomics Systems Inc. Other key executives at Singular Genomics Systems Inc include Chief Scientific Officer Eli N. Glezer , Chief Operating Officer Jyotsna Ghai , and Chief Commercial Officer Sam Ropp .
Singular Genomics Systems Inc (OMIC) Insider Trades Summary
Over the past 18 months, Andrew Spaventa made 1 insider transaction in Singular Genomics Systems Inc (OMIC) with a net purchase of 118,468. Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 420,000 shares made by Eli N. Glezer , a net sale of 631,648 shares made by Kim P. Kamdar ,
In summary, during the past 3 months, insiders sold 0 shares of Singular Genomics Systems Inc (OMIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 631,648 shares of Singular Genomics Systems Inc (OMIC) were sold and 538,468 shares were bought by its insiders, resulting in a net sale of 93,180 shares.
Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Singular Genomics Systems Inc Insider Transactions
Andrew Spaventa Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Spaventa. You might contact Andrew Spaventa via mailing address: 10931 N. Torrey Pines Road, Suite 100, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
